{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:58:49Z","timestamp":1790240329977,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"DOI":"10.1007\/s11910-026-01519-w","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:59:00Z","timestamp":1790236740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cognition in Cardiovascular Disease"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0193-6217","authenticated-orcid":false,"given":"Arash","family":"Salardini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayena","family":"Azarbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"1519_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105\u201325. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8.","journal-title":"Lancet Public Health"},{"key":"1519_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404:572\u2013628. https:\/\/doi.org\/10.1016\/S0140-6736(24)01296-0.","journal-title":"Lancet"},{"key":"1519_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamaneurol.2023.1331","volume":"80","author":"MC Johansen","year":"2023","unstructured":"Johansen MC, Ye W, Gross A, et al. Association between acute myocardial infarction and cognition. JAMA Neurol. 2023;80:723\u201331. https:\/\/doi.org\/10.1001\/jamaneurol.2023.1331.","journal-title":"JAMA Neurol"},{"key":"1519_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391\u20137. https:\/\/doi.org\/10.1016\/s0166-2236(99)01401-0.","journal-title":"Trends Neurosci"},{"key":"1519_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","volume":"18","author":"JM Wardlaw","year":"2019","unstructured":"Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18:684\u201396. https:\/\/doi.org\/10.1016\/S1474-4422(19)30079-1.","journal-title":"Lancet Neurol"},{"key":"1519_CR6","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1093\/brain\/awab273","volume":"144","author":"M Smirnov","year":"2021","unstructured":"Smirnov M, Destrieux C, Maldonado IL. Cerebral white matter vasculature: still uncharted? Brain. 2021;144:3561\u201375. https:\/\/doi.org\/10.1093\/brain\/awab273.","journal-title":"Brain"},{"key":"1519_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ana.21706","volume":"66","author":"JA Schneider","year":"2009","unstructured":"Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009;66:200\u20138. https:\/\/doi.org\/10.1002\/ana.21706.","journal-title":"Ann Neurol"},{"key":"1519_CR8","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1161\/STROKEAHA.110.598326","volume":"41","author":"JA Schneider","year":"2010","unstructured":"Schneider JA, Bennett DA. Where vascular meets neurodegenerative disease. Stroke. 2010;41:S144\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.110.598326.","journal-title":"Stroke"},{"key":"1519_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","volume":"277","author":"DA Snowdon","year":"1997","unstructured":"Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 1997;277:813\u20137. https:\/\/doi.org\/10.1001\/jama.1997.03540340047031.","journal-title":"JAMA"},{"key":"1519_CR10","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4:147ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748.","journal-title":"Sci Transl Med"},{"key":"1519_CR11","doi-asserted-by":"publisher","first-page":"18190","DOI":"10.1523\/JNEUROSCI.1592-13.2013","volume":"33","author":"JJ Iliff","year":"2013","unstructured":"Iliff JJ, Wang M, Zeppenfeld DM, et al. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci. 2013;33:18190\u20139. https:\/\/doi.org\/10.1523\/JNEUROSCI.1592-13.2013.","journal-title":"J Neurosci"},{"key":"1519_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease: one peptide, two pathways. Nat Rev Neurol. 2020;16:30\u201342. https:\/\/doi.org\/10.1038\/s41582-019-0281-2.","journal-title":"Nat Rev Neurol"},{"key":"1519_CR13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ncomms2230","volume":"3","author":"D Davalos","year":"2012","unstructured":"Davalos D, Ryu JK, Merlini M, et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun. 2012;3:1227. https:\/\/doi.org\/10.1038\/ncomms2230.","journal-title":"Nat Commun"},{"key":"1519_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296\u2013302. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.032.","journal-title":"Neuron"},{"key":"1519_CR15","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1161\/01.STR.12.6.723","volume":"12","author":"J Astrup","year":"1981","unstructured":"Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke. 1981;12:723\u20135. https:\/\/doi.org\/10.1161\/01.STR.12.6.723.","journal-title":"Stroke"},{"key":"1519_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/jcbfm.1991.132","volume":"11","author":"G Mies","year":"1991","unstructured":"Mies G, Ishimaru S, Xie Y, Seo K, Hossmann KA. Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab. 1991;11:753\u201361. https:\/\/doi.org\/10.1038\/jcbfm.1991.132.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1519_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/01.STR.13.4.522","volume":"13","author":"NA Lassen","year":"1982","unstructured":"Lassen NA. Incomplete cerebral infarction: focal incomplete ischemic tissue necrosis not leading to emollition. Stroke. 1982;13:522\u20133. https:\/\/doi.org\/10.1161\/01.STR.13.4.522.","journal-title":"Stroke"},{"key":"1519_CR18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/01.STR.27.4.761","volume":"27","author":"JH Garcia","year":"1996","unstructured":"Garcia JH, Lassen NA, Weiller C, Sperling B, Nakagawara J. Ischemic stroke and incomplete infarction. Stroke. 1996;27:761\u20135. https:\/\/doi.org\/10.1161\/01.STR.27.4.761.","journal-title":"Stroke"},{"key":"1519_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12916-014-0130-5","volume":"12","author":"RFAG de Bruijn","year":"2014","unstructured":"de Bruijn RFAG, Ikram MA. Cardiovascular risk factors and future risk of Alzheimer\u2019s disease. BMC Med. 2014;12:130. https:\/\/doi.org\/10.1186\/s12916-014-0130-5.","journal-title":"BMC Med"},{"key":"1519_CR20","doi-asserted-by":"publisher","first-page":"j2709","DOI":"10.1136\/bmj.j2709","volume":"357","author":"S Sabia","year":"2017","unstructured":"Sabia S, Dugravot A, Dartigues JF, et al. Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study. BMJ. 2017;357:j2709. https:\/\/doi.org\/10.1136\/bmj.j2709.","journal-title":"BMJ"},{"key":"1519_CR21","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1161\/STROKEAHA.110.579888","volume":"41","author":"ST Pendlebury","year":"2010","unstructured":"Pendlebury ST, Cuthbertson FC, Welch SJV, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke. 2010;41:1290\u20133. https:\/\/doi.org\/10.1161\/STROKEAHA.110.579888.","journal-title":"Stroke"},{"key":"1519_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41591-025-04101-y","volume":"32","author":"L Rivard","year":"2026","unstructured":"Rivard L, Khairy P, Talajic M, et al. Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial. Nat Med. 2026;32:297\u2013305. https:\/\/doi.org\/10.1038\/s41591-025-04101-y.","journal-title":"Nat Med"},{"key":"1519_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","volume":"333","author":"SH Simpson","year":"2006","unstructured":"Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333:15. https:\/\/doi.org\/10.1136\/bmj.38875.675486.55.","journal-title":"BMJ"},{"key":"1519_CR24","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1161\/01.STR.0000237236.88823.47","volume":"37","author":"V Hachinski","year":"2006","unstructured":"Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220\u201341. https:\/\/doi.org\/10.1161\/01.STR.0000237236.88823.47.","journal-title":"Stroke"},{"key":"1519_CR25","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s10654-015-0105-7","volume":"30","author":"MA Ikram","year":"2015","unstructured":"Ikram MA, van der Lugt A, Niessen WJ, et al. The Rotterdam Scan Study: design update 2016 and main findings. Eur J Epidemiol. 2015;30:1299\u2013315. https:\/\/doi.org\/10.1007\/s10654-015-0105-7.","journal-title":"Eur J Epidemiol"},{"key":"1519_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/EDE.0000000000000709","volume":"28","author":"SA Swanson","year":"2017","unstructured":"Swanson SA, Hern\u00e1n MA. Think globally, act locally: An introduction to the target trial emulation approach. Epidemiology. 2017;28:715\u20138. https:\/\/doi.org\/10.1097\/EDE.0000000000000709.","journal-title":"Epidemiology"},{"key":"1519_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, et al. Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol. 2024;81:255\u201363. https:\/\/doi.org\/10.1001\/jamaneurol.2023.5319.","journal-title":"JAMA Neurol"},{"key":"1519_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S1474-4422(21)00060-0","volume":"20","author":"NA Weaver","year":"2021","unstructured":"Weaver NA, Kuijf HJ, Aben HP, et al. Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts. Lancet Neurol. 2021;20:448\u201359. https:\/\/doi.org\/10.1016\/S1474-4422(21)00060-0.","journal-title":"Lancet Neurol"},{"key":"1519_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-158-5-201303050-00007","volume":"158","author":"S Kalantarian","year":"2013","unstructured":"Kalantarian S, Stern TA, Mansour M, Ruskin JN. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med. 2013;158:338\u201346. https:\/\/doi.org\/10.7326\/0003-4819-158-5-201303050-00007.","journal-title":"Ann Intern Med"},{"key":"1519_CR30","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jacc.2018.12.039","volume":"73","author":"D Conen","year":"2019","unstructured":"Conen D, Rodondi N, Muller A, et al. Relationships of overt and silent brain lesions with cognitive function in patients with atrial fibrillation. J Am Coll Cardiol. 2019;73:989\u201399. https:\/\/doi.org\/10.1016\/j.jacc.2018.12.039.","journal-title":"J Am Coll Cardiol"},{"key":"1519_CR31","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1093\/eurheartj\/ehac020","volume":"43","author":"M Kuhne","year":"2022","unstructured":"Kuhne M, Krisai P, Coslovsky M, et al. Silent brain infarcts impact on cognitive function in atrial fibrillation. Eur Heart J. 2022;43:2127\u201335. https:\/\/doi.org\/10.1093\/eurheartj\/ehac020.","journal-title":"Eur Heart J"},{"key":"1519_CR32","doi-asserted-by":"publisher","first-page":"e029623","DOI":"10.1161\/JAHA.123.029623","volume":"12","author":"M Li","year":"2023","unstructured":"Li M, Jiang C, Lai Y, et al. Genetic evidence for causal association between atrial fibrillation and dementia: a Mendelian randomization study. J Am Heart Assoc. 2023;12:e029623. https:\/\/doi.org\/10.1161\/JAHA.123.029623.","journal-title":"J Am Heart Assoc"},{"key":"1519_CR33","doi-asserted-by":"publisher","first-page":"18682","DOI":"10.1038\/s41598-021-98058-w","volume":"11","author":"SL Au Yeung","year":"2021","unstructured":"Au Yeung SL, Jiang C, Cheng KK, Cowling BJ, Schooling CM. Mendelian randomization study on atrial fibrillation and cardiovascular disease subtypes. Sci Rep. 2021;11:18682. https:\/\/doi.org\/10.1038\/s41598-021-98058-w.","journal-title":"Sci Rep"},{"key":"1519_CR34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689\u2013701. https:\/\/doi.org\/10.1016\/S1474-4422(10)70104-6.","journal-title":"Lancet Neurol"},{"key":"1519_CR35","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1161\/STROKEAHA.110.581975","volume":"41","author":"T Al-Khindi","year":"2010","unstructured":"Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41:e519\u201336. https:\/\/doi.org\/10.1161\/STROKEAHA.110.581975.","journal-title":"Stroke"},{"key":"1519_CR36","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1212\/WNL.37.8.1281","volume":"37","author":"CK Petito","year":"1987","unstructured":"Petito CK, Feldmann E, Pulsinelli WA, Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology. 1987;37:1281\u20136. https:\/\/doi.org\/10.1212\/WNL.37.8.1281.","journal-title":"Neurology"},{"key":"1519_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/01.STR.0000155727.82242.e1","volume":"36","author":"I Momjian-Mayor","year":"2005","unstructured":"Momjian-Mayor I, Baron JC. The pathophysiology of watershed infarction in internal carotid artery disease: review of cerebral perfusion studies. Stroke. 2005;36:567\u201377. https:\/\/doi.org\/10.1161\/01.STR.0000155727.82242.e1.","journal-title":"Stroke"},{"key":"1519_CR38","doi-asserted-by":"publisher","first-page":"e010117","DOI":"10.1161\/CIRCHEARTFAILURE.122.010117","volume":"16","author":"E Hillier","year":"2023","unstructured":"Hillier E, Covone J, Fischer K, et al. Microvascular dysfunction as a possible link between heart failure and cognitive dysfunction. Circ Heart Fail. 2023;16:e010117. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.010117.","journal-title":"Circ Heart Fail"},{"key":"1519_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1152\/physiol.00004.2023","volume":"38","author":"D Daou","year":"2023","unstructured":"Daou D, Gillette TG, Hill JA. Inflammatory mechanisms in heart failure with preserved ejection fraction. Physiol (Bethesda). 2023;38:217\u201330. https:\/\/doi.org\/10.1152\/physiol.00004.2023.","journal-title":"Physiol (Bethesda)"},{"key":"1519_CR40","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/ana.410360404","volume":"36","author":"KA Hossmann","year":"1994","unstructured":"Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994;36:557\u201365. https:\/\/doi.org\/10.1002\/ana.410360404.","journal-title":"Ann Neurol"},{"key":"1519_CR41","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ana.410140307","volume":"14","author":"WD Heiss","year":"1983","unstructured":"Heiss WD, Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol. 1983;14:294\u2013301. https:\/\/doi.org\/10.1002\/ana.410140307.","journal-title":"Ann Neurol"},{"key":"1519_CR42","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1161\/01.STR.0000217258.63925.6b","volume":"37","author":"S Arakawa","year":"2006","unstructured":"Arakawa S, Wright PM, Koga M, et al. Ischemic thresholds for gray and white matter: a diffusion and perfusion magnetic resonance study. Stroke. 2006;37:1211\u20136. https:\/\/doi.org\/10.1161\/01.STR.0000217258.63925.6b.","journal-title":"Stroke"},{"key":"1519_CR43","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1161\/01.STR.27.9.1641","volume":"27","author":"L Pantoni","year":"1996","unstructured":"Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke. 1996;27:1641\u20136. https:\/\/doi.org\/10.1161\/01.STR.27.9.1641.","journal-title":"Stroke"},{"key":"1519_CR44","doi-asserted-by":"publisher","first-page":"e1002143","DOI":"10.1371\/journal.pmed.1002143","volume":"13","author":"FJ Wolters","year":"2016","unstructured":"Wolters FJ, Mattace-Raso FUS, Koudstaal PJ, Hofman A, Ikram MA. Orthostatic hypotension and the long-term risk of dementia: a population-based study. PLoS Med. 2016;13:e1002143. https:\/\/doi.org\/10.1371\/journal.pmed.1002143.","journal-title":"PLoS Med"},{"key":"1519_CR45","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/jgs.15123","volume":"66","author":"MM Khan","year":"2018","unstructured":"Khan MM, Herrmann N, Gallagher D, et al. Cognitive outcomes after transcatheter aortic valve implantation: a metaanalysis. J Am Geriatr Soc. 2018;66:254\u201362. https:\/\/doi.org\/10.1111\/jgs.15123.","journal-title":"J Am Geriatr Soc"},{"key":"1519_CR46","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1093\/brain\/awr253","volume":"134","author":"GF Mitchell","year":"2011","unstructured":"Mitchell GF, van Buchem MA, Sigurdsson S, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene\/Environment Susceptibility-Reykjavik study. Brain. 2011;134:3398\u2013407. https:\/\/doi.org\/10.1093\/brain\/awr253.","journal-title":"Brain"},{"key":"1519_CR47","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","volume":"22","author":"M Duering","year":"2023","unstructured":"Duering M, Biessels GJ, Brodtmann A, et al. Neuroimaging standards for research into small vessel disease: advances since 2013. Lancet Neurol. 2023;22:602\u201318. https:\/\/doi.org\/10.1016\/S1474-4422(23)00131-X.","journal-title":"Lancet Neurol"},{"key":"1519_CR48","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1161\/STROKEAHA.123.046379","volume":"55","author":"L Deasy","year":"2024","unstructured":"Deasy L, Laurent-Chabalier S, Wacongne A, et al. Diagnostic accuracy of the posterior\/anterior periventricular white matter hyperintensity ratio to differentiate cerebral amyloid angiopathy from hypertensive arteriopathy. Stroke. 2024;55:2086\u201393. https:\/\/doi.org\/10.1161\/STROKEAHA.123.046379.","journal-title":"Stroke"},{"key":"1519_CR49","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.1038\/s41467-020-19111-2","volume":"11","author":"M Sargurupremraj","year":"2020","unstructured":"Sargurupremraj M, Suzuki H, Jian X, et al. Cerebral small vessel disease genomics and its implications across the lifespan. Nat Commun. 2020;11:6285. https:\/\/doi.org\/10.1038\/s41467-020-19111-2.","journal-title":"Nat Commun"},{"key":"1519_CR50","doi-asserted-by":"publisher","first-page":"e2412824","DOI":"10.1001\/jamanetworkopen.2024.12824","volume":"7","author":"M Sargurupremraj","year":"2024","unstructured":"Sargurupremraj M, Soumare A, Bis JC, et al. Genetic complexities of cerebral small vessel disease, blood pressure, and dementia. JAMA Netw Open. 2024;7:e2412824. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.12824.","journal-title":"JAMA Netw Open"},{"key":"1519_CR51","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.biopsych.2020.12.015","volume":"89","author":"W Sproviero","year":"2021","unstructured":"Sproviero W, Winchester L, Newby D, et al. High blood pressure and risk of dementia: a two-sample Mendelian randomization study in the UK Biobank. Biol Psychiatry. 2021;89:817\u201324. https:\/\/doi.org\/10.1016\/j.biopsych.2020.12.015.","journal-title":"Biol Psychiatry"},{"key":"1519_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and back. Physiol Rev. 2019;99:21\u201378. https:\/\/doi.org\/10.1152\/physrev.00050.2017.","journal-title":"Physiol Rev"},{"key":"1519_CR53","doi-asserted-by":"publisher","first-page":"831734","DOI":"10.3389\/fcvm.2021.831734","volume":"8","author":"M Yang","year":"2022","unstructured":"Yang M, Sun D, Wang Y, et al. Cognitive impairment in heart failure: landscape, challenges, and future directions. Front Cardiovasc Med. 2022;8:831734. https:\/\/doi.org\/10.3389\/fcvm.2021.831734.","journal-title":"Front Cardiovasc Med"},{"key":"1519_CR54","doi-asserted-by":"publisher","first-page":"e70535","DOI":"10.1002\/alz.70535","volume":"21","author":"S Palmqvist","year":"2025","unstructured":"Palmqvist S, Whitson HE, Allen LA, et al. Alzheimer\u2019s Association clinical practice guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer\u2019s disease within specialized care settings. Alzheimers Dement. 2025;21:e70535. https:\/\/doi.org\/10.1002\/alz.70535.","journal-title":"Alzheimers Dement"},{"key":"1519_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2004.09.002","volume":"226","author":"DW Desmond","year":"2004","unstructured":"Desmond DW. The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci. 2004;226:3\u20137. https:\/\/doi.org\/10.1016\/j.jns.2004.09.002.","journal-title":"J Neurol Sci"},{"key":"1519_CR56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1590\/S1980-57642009DN20200002","volume":"2","author":"GS Alves","year":"2008","unstructured":"Alves GS, Alves CEO, Lanna ME, et al. Subcortical ischemic vascular disease and cognition: a systematic review. Dement Neuropsychol. 2008;2:82\u201390. https:\/\/doi.org\/10.1590\/S1980-57642009DN20200002.","journal-title":"Dement Neuropsychol"},{"key":"1519_CR57","doi-asserted-by":"publisher","first-page":"e00364","DOI":"10.1002\/brb3.364","volume":"5","author":"CA Zamora","year":"2015","unstructured":"Zamora CA, Nauen D, Hynecek R, et al. Delayed posthypoxic leukoencephalopathy: a case series and review of the literature. Brain Behav. 2015;5:e00364. https:\/\/doi.org\/10.1002\/brb3.364.","journal-title":"Brain Behav"},{"key":"1519_CR58","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175:401\u20137. https:\/\/doi.org\/10.1001\/jamainternmed.2014.7663.","journal-title":"JAMA Intern Med"},{"key":"1519_CR59","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","volume":"179","author":"CAC Coupland","year":"2019","unstructured":"Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019;179:1084\u201393. https:\/\/doi.org\/10.1001\/jamainternmed.2019.0677.","journal-title":"JAMA Intern Med"},{"key":"1519_CR60","doi-asserted-by":"publisher","first-page":"e14324","DOI":"10.1002\/alz.14324","volume":"21","author":"RH Swartz","year":"2025","unstructured":"Swartz RH, Longman RS, Lindsay MP, et al. Canadian Stroke Best Practice Recommendations: vascular cognitive impairment, 7th edition practice guidelines update, 2024. Alzheimers Dement. 2025;21:e14324. https:\/\/doi.org\/10.1002\/alz.14324.","journal-title":"Alzheimers Dement"},{"key":"1519_CR61","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"Charidimou A, Boulouis G, Frosch MP, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022;21:714\u201325. https:\/\/doi.org\/10.1016\/S1474-4422(22)00208-3.","journal-title":"Lancet Neurol"},{"key":"1519_CR62","unstructured":"US Food and Drug Administration. FDA Clears First Blood Test Used in Diagnosing Alzheimer\u2019s Disease. Press Release. May 16. 2025. Accessed August 24, 2026. Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease"},{"key":"1519_CR63","doi-asserted-by":"publisher","first-page":"e214446","DOI":"10.1212\/WNL.0000000000214446","volume":"106","author":"F Gasparini","year":"2026","unstructured":"Gasparini F, Valletta M, Vetrano DL, et al. Kidney Function, Alzheimer Disease Blood Biomarkers, and Dementia Risk in Community-Dwelling Older Adults. Neurology. 2026;106:e214446. https:\/\/doi.org\/10.1212\/WNL.0000000000214446.","journal-title":"Neurology"},{"key":"1519_CR64","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jama.2018.21442","volume":"321","author":"JD Williamson","year":"2019","unstructured":"SPRINT MIND Investigators for the SPRINT Research Group, Williamson JD, Pajewski NM, Auchus AP, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321:553\u201361. https:\/\/doi.org\/10.1001\/jama.2018.21442.","journal-title":"JAMA"},{"key":"1519_CR65","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jama.2019.10551","volume":"322","author":"IM Nasrallah","year":"2019","unstructured":"Nasrallah IM, Pajewski NM, Auchus AP, et al. Association of intensive vs standard blood pressure control with cerebral white matter lesions. JAMA. 2019;322:524\u201334. https:\/\/doi.org\/10.1001\/jama.2019.10551.","journal-title":"JAMA"},{"key":"1519_CR66","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1093\/eurheartj\/ehaa726","volume":"41","author":"D Kim","year":"2020","unstructured":"Kim D, Yang PS, Sung JH, et al. Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study. Eur Heart J. 2020;41:4483\u201393. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa726.","journal-title":"Eur Heart J"},{"key":"1519_CR67","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","volume":"383","author":"P Kirchhof","year":"2020","unstructured":"Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383:1305\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2019422.","journal-title":"N Engl J Med"},{"key":"1519_CR68","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jaclp.2022.09.003","volume":"63","author":"Y Lee","year":"2022","unstructured":"Lee Y, et al. Cognitive change after left ventricular assist device implantation: a case series and systematic review. J Acad Consult Liaison Psychiatry. 2022;63:534\u201343. https:\/\/doi.org\/10.1016\/j.jaclp.2022.09.003.","journal-title":"J Acad Consult Liaison Psychiatry"},{"key":"1519_CR69","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamaneurol.2017.0083","volume":"74","author":"M Benn","year":"2017","unstructured":"Benn M, Nordestgaard BG, Frikke-Schmidt R. Association of LDL cholesterol levels and statin use with risk of Alzheimer disease and vascular dementia: a Mendelian randomization study. JAMA Neurol. 2017;74:577\u201384. https:\/\/doi.org\/10.1001\/jamaneurol.2017.0083.","journal-title":"JAMA Neurol"},{"key":"1519_CR70","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","volume":"19","author":"T Cukierman-Yaffe","year":"2020","unstructured":"Cukierman-Yaffe T, Gerstein HC, Colhoun HM, et al. Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial. Lancet Neurol. 2020;19:582\u201390. https:\/\/doi.org\/10.1016\/S1474-4422(20)30173-3.","journal-title":"Lancet Neurol"},{"key":"1519_CR71","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385:2255\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(15)60461-5.","journal-title":"Lancet"},{"key":"1519_CR72","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jama.2025.12923","volume":"334","author":"LD Baker","year":"2025","unstructured":"Baker LD, Espeland MA, Whitmer RA, et al. Structured vs self-guided multidomain lifestyle interventions for global cognitive function: the US POINTER randomized clinical trial. JAMA. 2025;334:681\u201391. https:\/\/doi.org\/10.1001\/jama.2025.12923.","journal-title":"JAMA"},{"key":"1519_CR73","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","volume":"146","author":"DM Lloyd-Jones","year":"2022","unstructured":"Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life\u2019s Essential 8: updating and enhancing the American Heart Association\u2019s construct of cardiovascular health. Circulation. 2022;146:e18\u201343. https:\/\/doi.org\/10.1161\/CIR.0000000000001078.","journal-title":"Circulation"},{"key":"1519_CR74","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jamaneurol.2023.1526","volume":"80","author":"JM Wardlaw","year":"2023","unstructured":"Wardlaw JM, Woodhouse LJ, Mhlanga II, et al. Isosorbide mononitrate and cilostazol treatment in patients with symptomatic cerebral small vessel disease: the Lacunar Intervention Trial-2 (LACI-2) randomized clinical trial. JAMA Neurol. 2023;80:682\u201392. https:\/\/doi.org\/10.1001\/jamaneurol.2023.1526.","journal-title":"JAMA Neurol"},{"key":"1519_CR75","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1474-4422(08)70046-2","volume":"7","author":"M Dichgans","year":"2008","unstructured":"Dichgans M, Markus HS, Salloway S, et al. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol. 2008;7:310\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(08)70046-2.","journal-title":"Lancet Neurol"},{"key":"1519_CR76","unstructured":"Lazar RM. The effect of treatment on cognitive function in patients with asymptomatic carotid artery stenosis: the CREST-2 trial. Presented at: International Stroke Conference 2026; Late-Breaking Science. Conference presentation; peer-reviewed cognitive manuscript pending."},{"key":"1519_CR77","doi-asserted-by":"publisher","first-page":"100150","DOI":"10.1016\/j.tjpad.2025.100150","volume":"12","author":"GD Rabinovici","year":"2025","unstructured":"Rabinovici GD, Selkoe DJ, Schindler SE, et al. Donanemab: appropriate use recommendations. J Prev Alzheimers Dis. 2025;12:100150. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100150.","journal-title":"J Prev Alzheimers Dis"},{"key":"1519_CR78","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14283\/jpad.2023.30","volume":"10","author":"J Cummings","year":"2023","unstructured":"Cummings J, Apostolova L, Rabinovici GD, et al. Lecanemab: appropriate use recommendations. J Prev Alzheimers Dis. 2023;10:362\u201377. https:\/\/doi.org\/10.14283\/jpad.2023.30.","journal-title":"J Prev Alzheimers Dis"},{"key":"1519_CR79","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/01.STR.0000049766.23453.05","volume":"34","author":"P Kapeller","year":"2003","unstructured":"Kapeller P, Barber R, Vermeulen RJ, et al. Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke. 2003;34:441\u20135. https:\/\/doi.org\/10.1161\/01.STR.0000049766.23453.05.","journal-title":"Stroke"},{"key":"1519_CR80","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/01.STR.0000202585.26325.74","volume":"37","author":"ECW van Straaten","year":"2006","unstructured":"van Straaten ECW, Fazekas F, Rostrup E, et al. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke. 2006;37:836\u201340. https:\/\/doi.org\/10.1161\/01.STR.0000202585.26325.74.","journal-title":"Stroke"},{"key":"1519_CR81","doi-asserted-by":"publisher","first-page":"e71361","DOI":"10.1002\/alz.71361","volume":"22","author":"ES van Etten","year":"2026","unstructured":"van Etten ES, Mahinrad S, Grill JD, et al. Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer\u2019s disease: an update from the Alzheimer\u2019s Association ARIA workgroup. Alzheimers Dement. 2026;22:e71361. https:\/\/doi.org\/10.1002\/alz.71361.","journal-title":"Alzheimers Dement"},{"key":"1519_CR82","doi-asserted-by":"publisher","first-page":"100446","DOI":"10.1016\/j.tjpad.2025.100446","volume":"13","author":"JA Zimmer","year":"2026","unstructured":"Zimmer JA, Sims JR, Evans CD, et al. Donanemab in early symptomatic Alzheimer\u2019s disease: results from the TRAILBLAZER-ALZ 2 long-term extension. J Prev Alzheimers Dis. 2026;13:100446. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100446.","journal-title":"J Prev Alzheimers Dis"},{"key":"1519_CR83","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330:512\u201327. https:\/\/doi.org\/10.1001\/jama.2023.13239.","journal-title":"JAMA"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01519-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-026-01519-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-026-01519-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:59:02Z","timestamp":1790236742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-026-01519-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1519"],"URL":"https:\/\/doi.org\/10.1007\/s11910-026-01519-w","relation":{},"ISSN":["1534-6293"],"issn-type":[{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"27 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AS is on the speakers bureau for Lily and have been invited to an advisory committee for Biogen. SA is the Medical Director and part owner of Indigo Infusions in San Antonio.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"52"}}